Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations

Endothelial Progenitor Cell Dysfunction in Polycystic Ovary Syndrome: Implications for The Genesis of Cardiovascular Diseases

Oxidized low-density lipoprotein alters endothelial progenitor cell populations.

Oxidized low-density lipoprotein (ox-LDL) is critical to atherosclerosis in hyperlipidemia. Bone marrow (BM)-derived endothelial progenitor cells (EPCs) are important to preventing atherosclerosis, and significantly decreased in hyperlipidemia. This study was to demonstrate ox-LDL and hyperlipidemia could exhibit similar effect on EPC population and the role of reactive oxygen species (ROS). RO...

Endothelial Progenitor Cell Research in Stroke

Background and Purpose—Stroke is the leading cause of disability in the Western world; however, few therapies are at hand to decrease this burden. Summary of Review—Endothelial progenitor cells (EPCs) have been introduced in cardiovascular medicine as factotums. EPCs can repair damaged endothelium and attenuate the development and progression of atherosclerosis. Also, EPCs can form new vessels ...

Kinin Receptors and Endothelial Progenitor Cell Dysfunction

The field of progenitor cell therapy appears to be poised to transform the management of many cardiovascular diseases. In particular, the use of bone marrow-derived mononuclear cells (BM-MNCs) and endothelial progenitor cells (EPCs) have shown indications of improved cardiac function post–myocardial infarction (MI), with a recent metaanalysis showing a highly significant mean improvement in glo...

Endothelial Progenitor Cell in Cardiovascular Diseases